Nouvelle déclaration d'incident
No de la demande: 2012-5447
Numéro de référence du titulaire d'homologation: 4806854
Nom du titulaire (nom légal complet, aucune abbréviation): Sure-Gro Inc.
Adresse: 150 Savannah Oaks Dr.
Ville: Brantford
État: Ontario
Pays: Canada
Code postal /Zip: N3V 1E7
Incident chez un animal domestique
Pays: CANADA
État: ONTARIO
ARLA No d'homologation 28352 ARLA No de la demande d'homologation EPA No d'homologation.
Nom du produit: Wilson Predator Rat and Mouse Killer Blok
Inconnu
Inconnu
Propriétaire de l'animal
Dog / Chien
Chihuahua
1
Inconnu
6
6
kg
Orale
Unknown / Inconnu
Unknown / Inconnu
Système
Unknown / Inconnu
Oui
Inconnu
Unknown/Inconnu
Accidental ingestion/Ingestion accident.
(p.ex. description des symptômes tels que la fréquence et la gravité
DVM calling to obtain help. Pet ate rodenticide yesterday. The owner came home last night and found stool that had the same color as the bait. She does not know when the dog ingested it but she knows that he got 20 g. Current asymptomatic at the clinic. Explained to Dr. (NAME) that onset of action is usually 3-7 days post ingestion. Recommended starting Vitamin K1 today. They only have injectable form. Told DVM there is a chance for anaphylaxis with injection. She plans to use the injectable orally instead. Follow up call with pet owner was able to be connected as the phone number given was not in working order. Clinic however stated that the pet is on a 30 day supply of k1. one 10mg tab twice daily for 30 days. A PT was recommended to the owner by the clinic, however, the owner has yet to schedule it. The clinic does not know if the feces is the normal color.
Mineure
The information contained in this report is based on self-reported statements provided to the registrant during telephone Interview(s). These self-reported descriptions of an incident have not been independently verified to be factually correct or complete descriptions of the incident. For that reason, information contained in this report does not and can not form the basis for a determination of whether the reported clinical effects are causally related to exposure to the product identified.